"Chiphybio: Obtained Purification Method and Application Patent Certificate of Pneumococcal Capsular Polysaccharide"

Chi Fei Biology announced that the company and its wholly-owned subsidiaries, Beijing Zhifei Luluzhu Biological Pharmaceutical Co., Ltd. and Anhui Zhifei Longke Ma Biological Pharmaceutical Co., Ltd., recently obtained the invention patent certificate issued by the State Intellectual Property Office of the People's Republic of China. The invention patent is titled "Purification Method and Application of Pneumococcal Capsular Polysaccharide." The patent application date is June 18, 2025, the authorization announcement date is April 3, 2026, and the patent holders are Zhifei Longke Ma, Chi Fei Biology, and Zhifei Luluzhu.